The Lipstick Effect Is Real: Why Aesthetics Survives Every Downturn

Here's a fact that should change how you think about a downturn: in the depths of the Great Depression, as nearly every category of consumer spending collapsed, cosmetics sales rose. The pattern has held in recession after recession since, and it has a name, the lipstick effect, and it is the single most important idea for any med spa owner watching the economy with a knot in their stomach.

This isn't a "stay positive" pep talk. It's a structural argument. Aesthetics does not behave like other discretionary spending, and the reasons it doesn't are specific, durable, and, for an owner willing to act on them, exploitable. Most med spas spend a downturn bracing: trimming budgets, bracing the team, waiting for the weather to clear. A small number spend it quietly taking share. The difference between the two has almost nothing to do with luck and almost everything to do with whether you understand why your category is resilient and then run the business like you believe it.

The lipstick effect, and why it's real

The lipstick effect describes a stubborn consumer behavior: when money gets tight, people cut the big, deferrable purchases (the car, the vacation, the kitchen renovation) but they hold on to the small luxuries that make them feel good and look good. The term comes from the observation that lipstick sales tend to climb when the broader economy sinks. It's the affordable indulgence that survives when the expensive ones get cut.

What makes this more than a cute retail anecdote is that researchers have actually studied it. Hill and colleagues, writing in the Journal of Personality and Social Psychology, found that economic uncertainty increased consumers' desire to spend on appearance enhancing products. Their work framed it as more than thrift era coping: there's a documented psychological mechanism in which a tougher economy heightens the pull toward looking one's best. The headline finding is the one to sit with: in their experiments, signals of a worsening economy did not depress the appetite for beauty spending. They sharpened it.

When the economy gets shaky, small appearance purchases don't become frivolous. They become more important: an affordable way to hold on to confidence and a sense of control when everything larger feels out of reach.

That reframing matters for how you read your own schedule in a soft year. A client who postpones a big ticket package and books a smaller appearance treatment instead isn't "spending less because times are hard." She's doing exactly what a century of consumer behavior predicts: protecting the small luxury precisely because times are hard. The instinct most owners have, to assume aesthetic demand evaporates in lockstep with the stock market, is the instinct the research contradicts.

For a med spa, that's not trivia. It means a meaningful slice of your demand is anchored to a behavior that has survived a century of recessions. You are not selling a pure want to have that disappears the moment a household tightens its belt. You are selling something closer to an emotional staple, and emotional staples are sticky.

The structural advantage nobody talks about

Layer a second fact on top of the consumer psychology, and the picture gets stronger still: med spas are cash pay. You collect at the time of service. No claims, no contractual write offs, no waiting 45 days for a payer to reimburse a discounted rate, no risk that a policy change next quarter rewrites your economics. The American Med Spa Association's work on recession resilient practices keeps returning to this point because it's foundational: while insurance dependent healthcare businesses are exposed to reimbursement cycles, prior authorizations, and third party policy shifts, a med spa's cash flow is immediate and fully within its own control.

It's worth dwelling on how rare that is in healthcare. A dental or medical practice that takes insurance produces work today and collects on it weeks later, after a payer has reviewed, adjusted, and paid a contracted fraction of the posted fee. The gap between production and collection is float (real money tied up while you wait) and the size of the collection is dictated by a contract you don't control. A med spa skips all of it. The card is run when the treatment is delivered. What you charged is what you keep, and you keep it now.

In an uncertain economy, that control is worth more than almost anything. Recessions punish businesses that depend on someone else's timeline and someone else's solvency to get paid. They are far gentler to businesses that collect their own revenue at the point of sale. This is the structural reason aesthetics held up in the last downturn while plenty of "safer looking" businesses (ones with long receivables, thin margins, and reimbursement exposure) did not. Cash pay isn't just convenient. In a contraction, it's a hedge.

Injectables democratize the downturn

The third dynamic is about price points, and it's the one owners most often miss because they watch the wrong number. When confidence dips, the high ticket treatments (the surgical procedures, the multi thousand dollar packages, the things a client can comfortably defer to next year) soften. They behave like the car and the renovation, because that's what they are: large, postponable purchases. If you only watch your highest ticket line, a downturn looks like a cliff.

But the lower ticket, accessible treatments do something different. They don't just hold; they often capture the mid income client who is trading down from something bigger and still wants to feel good. A neuromodulator appointment or an accessible entry treatment becomes the affordable luxury (the lipstick) for the client who's postponing the larger spend but has no intention of postponing herself. The category doesn't lose that client. It receives her at a lower ticket.

That's the move that's easy to misread as a loss. A client trading from a $4,000 package to a $400 treatment looks, on a spreadsheet that only tracks average ticket, like demand evaporating. It isn't. It's demand redistributing: out of the deferrable tier and into the resilient one. The question isn't whether your average ticket dips in a downturn. It's whether you are positioned to catch the redistribution when it happens. The spas built around accessible entry services and an easy on ramp catch it. The spas built only around premium packages watch it walk to a competitor who made starting easier.

Here's the behavior, tier by tier, in one picture:

The takeaway from the table isn't "abandon premium work." It's that a downturn changes the shape of your demand, and a spa that only sells the left column feels a recession far harder than one that has built a deliberate, attractive right column to catch the clients who are trading down rather than out.

Why discounting is the wrong instinct

All of which leads to the single most expensive reflex in a soft market: the discount. When bookings wobble, the gut reaction is to cut prices (a flash sale on tox, a percentage off packages, a "recession special"). It feels responsive. It is almost always a mistake, and the lipstick effect is exactly why.

You don't have a willingness problem in a downturn. The research says the desire to spend on appearance holds up. What you have is a barrier to start problem: clients are more cautious about committing to something large and unfamiliar. Discounting solves the wrong one. Worse, it does real damage: a sale teaches your best, most loyal clients to wait for the next one, so you erode the full fee revenue you depend on most precisely when margin is scarcest. You train demand to be patient at the exact moment you need it to be active. And once a market knows your prices move, getting them back up is brutal.

The better lever is to lower the barrier to start without lowering your value. That's not a discount; it's an on ramp. Two tools do the work:

• Entry tier services. A genuinely accessible first treatment (small, fast, low commitment) that lets a cautious or trading down client say yes without a big leap. It's not your full menu at a markdown; it's a designed first step at its own honest price, built to convert the lipstick effect client who wants in but not all in.
• Membership. A monthly plan turns the occasional indulgence into a routine the client has already decided to keep. It makes consistency easy, smooths your cash flow into something predictable, and, crucially, it's a commitment to value, not a markdown on it. Members don't wait for sales; they're already in.

The contrast is the whole point:

You're not making yourself cheaper. You're making yourself easy to begin with, which is precisely what a hesitant, trade down client needs from you, and precisely what a discount fails to deliver.

The move that turns a recession into market share

Everything above is the demand side, and it's genuinely encouraging. But resilience isn't a strategy on its own; it's a head start you can still squander. The thing that converts a recession into market share is the same thing it always is, and it's the thing most owners get wrong: what you do with your marketing when everyone else gets scared.

When competitors panic and pull their budgets, two things happen at once. Attention gets cheaper, because fewer advertisers are bidding for the same eyes. And your message gets louder for the same money, because there's less noise competing with it. A downturn is, counterintuitively, one of the best times to be visible: not because you should spend recklessly, but because every dollar of presence stretches further when the field clears. The med spas that come out of a contraction bigger are, almost without exception, the ones that stayed visible while the others went dark, captured the clients those competitors abandoned, and then kept that share when the market recovered.

The discipline here is not "spend more." It's spend precisely. Hold your visibility, but move your budget toward the entry tier offers and the audiences that are actually converting this week, and cut the genuine waste rather than the presence itself. The owners who go dark are reacting to fear; the owners who slash blindly are reacting to a spreadsheet. The ones who win are doing something harder: staying in the market and reallocating with a scalpel.

That real time reallocation (reading what's working right now and moving spend toward it, day by day, instead of setting a budget in January and hoping) is the job of your Campaign Strategy agent. The point of precision is that you spend the same dollars better: more behind the accessible treatments the lipstick effect is driving, less behind the deferrable packages a cautious market is postponing. You don't survive a downturn by spending less. You survive it by spending exactly.

And the channel matters as much as the discipline. A great deal of aesthetic demand isn't searched: nobody types "I want to feel better about myself" into a search bar. It's discovered, in the scroll, when the right treatment meets the right person at the right moment. That makes the social feed the place a quiet market hands you the cheapest attention of the cycle, because it's the channel competitors abandon first when they get nervous. Keeping your entry offers in front of the right clients there (without torching budget on the wrong ones) is the job of your Meta Ads agent. When the feed gets quiet because everyone else retreated, the spa that stayed is the one the trading down client finds.

The 2026 takeaway

A downturn is frightening if you assume aesthetics behaves like every other discretionary category. It doesn't, and the reasons it doesn't are the most important thing you can internalize as an owner. The lipstick effect is real and peer reviewed: appearance spending holds up, sometimes rises, when the economy wobbles. The cash pay model is a genuine structural hedge, putting your collections on your own timeline instead of a payer's. And accessible treatments actually gain ground as clients trade down rather than out, redistributing your demand toward the tier you can serve at scale.

None of that protects the owner who reacts to fear, who discounts and trains demand to wait, or goes quiet and hands the clearing market to whoever stayed. The structural advantages buy you a head start; what you do with it decides the outcome. The med spa that treats a recession as a share taking opportunity (resilient demand met with disciplined, precise, unflinching visibility) doesn't just survive the cycle. It owns more of the market on the other side. Don't brace for the downturn. Position for the recovery you'll already be leading.